News Summary
Dr. Jeffrey Cummings is spearheading Alzheimer’s research at the University of Nevada, Las Vegas, aiming to improve treatment options for the growing number of Alzheimer’s patients in the state. With over 40 years of experience, significant funding investments, and innovative projects, Cummings is transforming the landscape of Alzheimer’s research, focusing on drug development and advanced diagnostic capabilities. His efforts include establishing new research facilities and attracting talented scientists to combat this pressing health issue effectively.
Las Vegas, NV – Dr. Jeffrey Cummings, a leading figure in Alzheimer’s research, is pioneering efforts to combat the increasing prevalence of the disease at the University of Nevada, Las Vegas (UNLV). As the director of the Chambers-Grundy Center for Transformative Neuroscience and a research professor in the Department of Brain Health, Cummings is focused on advanced neuroscience tools and drug development to support approximately 50,000 Alzheimer’s and dementia patients in Nevada.
With over 40 years of experience in the field, Cummings has made significant contributions to Alzheimer’s research, including his role as the founding director of the Cleveland Clinic Lou Ruvo Center for Brain Health since its inception in 2010. He brought his expertise to UNLV in 2019 after directing the Alzheimer’s Disease Research Center at UCLA and training in London. His scholarly output includes more than 900 published works, making him a highly respected figure in the scientific community.
Under Cummings’ guidance, UNLV has seen a substantial expansion in its Alzheimer’s research capabilities, particularly through a $3.2 million investment from the Alzheimer’s Drug Discovery Foundation. This funding aims to establish a biomarker observatory that will enhance diagnostic capabilities for Alzheimer’s disease. Additionally, a new Alzheimer’s Innovation Incubator, supported by the National Institute on Aging, has been put in place to foster student-driven research and practical applications in the field.
Cummings has also played a pivotal role in developing the Appropriate Use Recommendations for newly approved Alzheimer’s drugs, a resource that has reached over 40,000 accesses and is now utilized by various healthcare systems including the Cleveland Clinic. His work has garnered recognition, ranking him as the top scholar in his fields on ScholarGPS and the second most prolific scholar in Alzheimer’s disease and cognitive disorder research globally.
Despite challenges such as federal funding cuts and a cautious venture capital environment, Cummings is optimistic about the future of Alzheimer’s drug development. Since 2021, three new medications for the condition have received approval — a significant milestone following a nearly two-decade drought of new treatments. Innovations in biomarkers have further revolutionized the field, providing researchers the ability to observe drug effects on the brain more directly rather than relying solely on changes in patient memory.
In response to the growing number of Alzheimer’s cases, Cummings is dedicated to attracting new researchers and scientists to tackle this pressing issue. He aims to build a strong team at UNLV that can contribute to the advancement of treatment options and deepen understanding of Alzheimer’s disease.
Cummings leads an impressive array of faculty at UNLV, which includes specialists in various fields such as Gabriele Wulf in motor learning, Bing Zhang in gamma ray research, and Francis Cucinotta in space exploration. Collectively, these faculty members position UNLV as a hub for cutting-edge research and innovation.
Additionally, the Chambers-Grundy Center for Transformative Neuroscience is exploring the use of new monitoring devices designed to enhance healthcare delivery for Alzheimer’s patients. This proactive approach aims to address the myriad challenges faced by individuals suffering from degenerative brain conditions, paving the way for improved management and eventual breakthroughs in treatment.
In summary, Dr. Jeffrey Cummings is at the forefront of Alzheimer’s research at UNLV, leading innovative projects aimed at combating the rising tide of the disease in Nevada. With a strong research foundation and a commitment to developing new treatment methodologies, Cummings and his team are dedicated to bringing more effective solutions to those affected by Alzheimer’s and dementia.
Deeper Dive: News & Info About This Topic
HERE Resources
UNLV Researcher Achieves Global Recognition in Dementia Studies
Additional Resources
- Las Vegas Sun: UNLV Educator at the Forefront in Fight to Cure Alzheimer’s
- Google Search: Alzheimer’s research UNLV
- KTVO: UNLV Loses Millions in Federal Research Funding
- Google Scholar: Alzheimer’s research funding
- Las Vegas Review-Journal: Loss of American Innovation at UNLV
- Encyclopedia Britannica: Alzheimer’s disease
- The Nevada Independent: Trump Administration Defunds UNLV Research
- Google News: UNLV Alzheimer’s research
Author: STAFF HERE LAS VEGAS WRITER
LAS VEGAS STAFF WRITER The LAS VEGAS STAFF WRITER represents the experienced team at HERELasVegas.com, your go-to source for actionable local news and information in Las Vegas, Clark County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Electric Daisy Carnival, World Series of Poker, and Consumer Electronics Show. Our coverage extends to key organizations like the Las Vegas Chamber of Commerce and Three Square Food Bank, plus leading businesses in hospitality and entertainment that power the local economy such as MGM Resorts International, Caesars Entertainment, and Las Vegas Sands. As part of the broader HERE network, we provide comprehensive, credible insights into Nevada's dynamic landscape.
